newsfilter
← Latest News
PR Newswire·

Scopus BioPharma Announces Closing of Underwriters' Over-Allotment Option in Full

Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of the underwriters' over-allotment option in full, bringing total follow-on public...